Improvements in Histologic Features and Diagnosis associated with Improvement in Fibrosis in NASH : Results from the NASH Clinical Research Network Treatment Trials-Reference-Cited by-同舟云学术

Improvements in Histologic Features and Diagnosis associated with Improvement in Fibrosis in NASH : Results from the NASH Clinical Research Network Treatment Trials

Published:2018-12-14 Issue: Volume: Page:
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Brunt Elizabeth M¹,Kleiner David E²,Wilson Laura A³,Sanyal Arun J⁴,Neuschwander‐Tetri Brent A⁵,

Affiliation:

1. Department of Pathology and Immunology Washington University School of Medicine St. Louis MO 63110

2. Laboratory of Pathology National Cancer Institute Bethesda MD 20892

3. Johns Hopkins University Baltimore MD 21218

4. Virginia Commonwealth University School of Medicine Richmond VA 23284

5. Division of Gastroenterology and Hepatology Saint Louis University School of Medicine St. Louis MO 63104

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30418

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD);Journal of Hepatology;2024-09

2. Outcome prediction in metabolic dysfunction‐associated steatotic liver disease using stain‐free digital pathological assessment;Liver International;2024-08-07

3. AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases;Nature Medicine;2024-08-07

4. Pipeline of New Drug Treatment for Non-alcoholic Fatty Liver Disease/Metabolic Dysfunction-associated Steatotic Liver Disease;Journal of Clinical and Translational Hepatology;2024-07-31

5. Sex Differences Affect the NRF2 Signaling Pathway in the Early Phase of Liver Steatosis: A High-Fat-Diet-Fed Rat Model Supplemented with Liquid Fructose;Cells;2024-07-24